Fundamental Analysis of ACLARION INC(NASDAQ:ACON) stock

Fundamental Rating

ACON gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. ACON has a bad profitability rating. Also its financial health evaluation is rather negative. ACON has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ACON has reported negative net income.

In the past year ACON has reported a negative cash flow from operations.

1.2 Ratios

ACON's Return On Assets of -191.03% is on the low side compared to the rest of the industry. ACON is outperformed by 94.44% of its industry peers.

The Return On Equity of ACON (-359.31%) is worse than 83.33% of its industry peers.

		Industry Rank	Sector Rank
ROA	-191.03%
ROE	-359.31%
ROIC	N/A

ROA(3y)-257.22%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACON so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.

ACON has more shares outstanding than it did 1 year ago.

The debt/assets ratio for ACON is higher compared to a year ago.

2.2 Solvency

ACON has an Altman-Z score of -25.82. This is a bad value and indicates that ACON is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of ACON (-25.82) is worse than 94.44% of its industry peers.

ACON has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.

ACON has a worse Debt to Equity ratio (0.47) than 66.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.47
Debt/FCF	N/A
Altman-Z	-25.82

ROIC/WACCN/A

WACC8.59%

2.3 Liquidity

A Current Ratio of 1.28 indicates that ACON should not have too much problems paying its short term obligations.

The Current ratio of ACON (1.28) is comparable to the rest of the industry.

ACON has a Quick Ratio of 1.28. This is a normal value and indicates that ACON is financially healthy and should not expect problems in meeting its short term obligations.

With a Quick ratio value of 1.28, ACON perfoms like the industry average, outperforming 41.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.28
Quick Ratio	1.28

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.81% over the past year.

Looking at the last year, ACON shows a very negative growth in Revenue. The Revenue has decreased by -35.21% in the last year.

ACON shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.77% yearly.

EPS 1Y (TTM)85.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%94.79%

Revenue 1Y (TTM)-35.21%

Revenue growth 3Y15.77%

Revenue growth 5YN/A

Sales Q2Q%-35.74%

3.2 Future

ACON is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -19.76% yearly.

The Revenue is expected to decrease by -6.91% on average over the next years.

EPS Next Y-128.95%

EPS Next 2Y-19.76%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-75.67%

Revenue Next 2Y-6.91%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ACON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ACON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as ACON's earnings are expected to decrease with -19.76% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-19.76%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ACON does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ACLARION INC

NASDAQ:ACON (11/22/2024, 6:53:35 PM)

After market: 0.1758 0 (0%)

0.1758

0 (-1.73%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.77M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-191.03%
ROE	-359.31%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.02

Health

		Industry Rank	Sector Rank
Debt/Equity	0.47
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.28
Quick Ratio	1.28
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)85.81%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-128.95%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-35.21%

Revenue growth 3Y15.77%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

ACLARION INC (ACON)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens